Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


BAXTER INTL   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2020201920182017201620152014201320122011
Period End Date12/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/201212/31/2011
Sales11,673.0011,362.0011,099.0010,584.0010,163.009,968.0010,719.009,413.0013,936.0013,893.00
Total Revenues11,673.0011,362.0011,099.0010,584.0010,163.009,968.0010,719.009,413.0013,936.0013,893.00
Cost of goods sold7,086.006,601.006,340.006,110.006,047.005,822.006,138.005,251.006,802.006,847.00
Gross Profit4,587.004,761.004,759.004,474.004,116.004,146.004,581.004,162.007,134.007,046.00
Goodwill amortization--------------------
Research and development expenses521.00595.00654.00615.00646.00603.00610.00582.001,081.00946.00
In-process research and development expense--------------------
Marketing and administrative expenses2,469.002,535.002,620.002,627.002,725.003,094.003,315.003,084.003,283.003,154.00
Other operating income19.00141.0099.0056.000.00----------
Operating income1,616.001,772.001,584.001,288.00745.00449.00656.00496.00----
Net interest expense134.0071.0045.0055.0066.00126.00145.00128.0087.0054.00
Restructuring charges, net--------------------
Other income (expense) net(190.00)(731.00)78.00(133.00)4,275.00105.00(21.00)7.00155.00(83.00)
Other special charges--------------------
Charge relating to A, AF and AX series dialyzers--------------------
Income (loss) before income taxes1,292.00970.001,617.001,100.004,954.00428.00490.00375.002,838.002,809.00
Income tax expense (benefit)182.00(41.00)65.00491.00(12.00)35.0033.0060.00555.00553.00
Current: Federal7.008.0021.00--10.00(251.00)(305.00)--122.0075.00
Current State and local(7.00)3.00(1.00)--(3.00)(6.00)(44.00)--55.0032.00
Current International270.00258.00308.00--282.00345.00398.00--395.00274.00
Deferred: Federal(99.00)(140.00)(228.00)--(286.00)(9.00)63.00--112.00155.00
Deferred State and local5.00(29.00)0.00--3.00(20.00)7.00--(81.00)(6.00)
Deferred International6.00(141.00)(35.00)--(18.00)(24.00)(86.00)--(48.00)23.00
Income from Continuing Operations1,110.001,011.001,552.00609.004,966.00393.00457.00315.002,283.00--
Income (loss) from discontinued operations----(6.00)(7.00)(1.00)575.002,040.001,697.0043.00--
Income from continuing operations before cumulative effect of accounting changes--------------------
Cumulative effect of accounting changes, net of income tax benefit--------------------
Net Income(Loss) before Preferred Dividend & Noncontrolling Interest1,110.001,011.001,546.00602.00----------2,256.00
Less- Net income attributable to noncontrolling interests8.0010.00--------------32.00
Net income (loss) attributable to common stockholders1,102.001,001.001,546.00602.004,965.00968.002,497.002,012.002,326.002,224.00
Earnings per basic common share Continuing operations2.171.972.911.129.100.720.840.584.14--
Earnings per basic common share Discontinued operations----(0.01)(0.01)(0.01)1.063.773.120.08--
Cumulative effect of accounting changes--------------------
Net Earnings Per Share (Basic)2.171.972.901.119.091.784.613.704.223.91
Earnings per diluted common share Continuing operations2.131.932.841.109.010.720.830.574.11--
Continuing operations, before cumulative effect of accounting changes--------------------
Earnings per diluted common share Discontinued operations----(0.01)(0.02)--1.043.733.090.07--
Cumulative effect of accounting changes--------------------
Net Earnings Per Share (Diluted)2.131.932.831.089.011.764.563.664.183.88
Weighted Average Shares Outstanding (Basic)509.00509.00534.00543.00546.00545.00542.00543.00551.00569.00
Weighted Average Shares Outstanding (Diluted)517.00519.00546.00555.00551.00549.00547.00549.00556.00573.00